Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1984;11(4):120-2.

Treatment of IUD related menorrhagia by indomethacin

S Yarkoni, S O Anteby
  • PMID: 6437699
Clinical Trial

Treatment of IUD related menorrhagia by indomethacin

S Yarkoni et al. Clin Exp Obstet Gynecol. 1984.

Abstract

Indomethacin, prostaglandin synthetase inhibitor was tested in 9 women wearing a lippes loop IUD. These women suffered from excessive bleeding with a mean menstrual blood loss of more than 100 ml. The effect was studied by quantifying menstrual blood loss in a double blind 4 periods crossover study. The mean percentage reduction during treatment was of 57 percent. No significant placebo effect was observed. The effect of indomethacin support the contention that IUD's associated menorrhagia, is connected to an abnormal prostaglandin synthetase in the endometrium.

PIP: Indomethacin, a prostaglandin synthetase inhibitor, was tested in 9 women wearing a Lippes loop IUD. These women suffered from excessive bleeding with a mean menstrual blood loss of more than 100 ml. The effect was studied by quantifying menstrual blood loss in a double blind 4 periods crossover study. The mean percentage of reduction during treatment was 57%. No significant placebo effect was observed. The effect of indomethacin supports the contention that IUD associated menorrhagia is connected to an abnormal prostaglandin synthetase in the endometrium.

PubMed Disclaimer

Publication types